To the best of our knowledge, this study is one of the largest cohorts analyzing the association between the use of aspirin, overall survival in colon cancer patients and mutational status of BRAF and KRAS, however numbers were too small for any additional subgroup analyses. The gene discussed is KRAS; the disease is malignant colon neoplasm.